Comparison of Buprenorphine and Methadone - 3
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000334 |
Recruitment Status
:
Completed
First Posted
: September 21, 1999
Last Update Posted
: January 31, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Opioid-Related Disorders | Drug: Buprenorphine | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 0 participants |
Primary Purpose: | Treatment |
Official Title: | Pharmacological Comparison of Buprenorphine and Methadone |
Actual Study Start Date : | December 1, 2002 |
Actual Primary Completion Date : | November 1, 2004 |
Actual Study Completion Date : | January 15, 2005 |
- Withdrawal severity
- Opiate agonist symptoms

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 23 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000334
United States, District of Columbia | |
Washington DC VA | |
Washington, District of Columbia, United States, 20422 |
Principal Investigator: | Steven Deutsch, M.D. | Washington D.C. Veterans Affairs Medical Center |
ClinicalTrials.gov Identifier: | NCT00000334 History of Changes |
Other Study ID Numbers: |
NIDA-3-0009-3 Y01-3-0009-3 |
First Posted: | September 21, 1999 Key Record Dates |
Last Update Posted: | January 31, 2017 |
Last Verified: | December 2002 |
Additional relevant MeSH terms:
Opioid-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders Buprenorphine Methadone Analgesics, Opioid Narcotics |
Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents Narcotic Antagonists Antitussive Agents Respiratory System Agents |